Ikena Oncology, Inc.IKNANASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank57
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-4.00%
↓ 112% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
33.57%
Historical baseline
PeriodValue
2025-4.00%
202442.61%
2023-6.11%
2022-21.82%
2021-60.69%
2020-181.06%
2019499.66%
20180.00%